Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compounds and assays for controlling Wnt activity

a technology of compound and assay, applied in the field of therapeutic methods, can solve the problems of impaired glucose tolerance when challenged, impaired glucose-induced insulin secretion from the pancreatic islets, and impaired glucose toleran

Active Publication Date: 2012-12-20
ENZO BIOCHEM
View PDF3 Cites 29 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although fasted blood glucose and insulin levels were normal in the mutant strains, they showed a defect in glucose tolerance when challenged.
These animals also showed impaired clearance of chylomicron remnants and also impaired glucose-induced insulin secretion from the pancreatic islets.
Thus, the only limitation of a candidate molecule being screened for an ability to bind to a target molecule is solely based on the availability of its structure and the computational power devoted to the analysis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compounds and assays for controlling Wnt activity
  • Compounds and assays for controlling Wnt activity
  • Compounds and assays for controlling Wnt activity

Examples

Experimental program
Comparison scheme
Effect test

example 1

Virtual Screening

[0167]The designs of the various compounds that comprise a virtual library are shown in FIGS. 1-13 and are designated as compounds M71-M364. Another series of compounds were derived from the NCl database / chemical library as well as commercial database / chemical libraries from ChemDiv, Inc. (San Diego, Calif.), Chembridge Corporation (San Diego, Calif.) and Life Chemicals USA (Orange, Conn.). This series is referred to as Enzo001-Enzo438. Compounds derived from the M71-M364 series are novel compounds of a virtual library that require synthesis before testing in a biological assay. On the other hand, the Enzo001-Enzo438 series represents a physical library—a series of compounds that have already been synthesized and are readily available for testing. These compounds were screened as described previously in related pending U.S. patent application Ser. No. 10 / 849,067 and candidates were selected on the basis of a predicted binding to Domain III of LRP5 / 6.

[0168]Although a...

example 2

Synthesis of Gallocyanine Analogues

[0169]One compound that has been of interest in the related patent applications is IIIC3, otherwise known as Gallocyanine and NCl 8642. A number of the compounds described in Example 1 are analogues of this compound and as described above, underwent a virtual screening step to select the best candidates. However, as mentioned in the text, analogues of compounds that show effectiveness may also be tested in the absence of such a screening step. Thus, a synthesis was carried out that produced at least two different IIIC3 analogues that were tested directly without the screening step. In this process, a mixture of 100 mg (0.33 mMoles) of gallocyanine (chloride free), 50 ml of methanol, 38 μl (0.33 mMoles) of 2,6-lutidine and propyliodide (0.5 ml) were placed in a 150 ml pressure vessel with a stirrer. The mixture was stirred and heated at approximately 110° C. for 4 days. After concentration in vacuo, the residue was washed with 5 ml of ethanol. Solid...

example 3

Effects of Gallocyanine Analogues on Mice Placed on a High Caloric Diet

[0170]This experiment was carried out essentially as described previously with IC15, IIIC3 and M01 in related pending U.S. patent application Ser. No. 11 / 598,916 with the exception of using the gallocyanine analogue preparation from Example 2 above. 8 week old C57 / BL6J mice were placed on a high fat diet for 60 days and then treated on a daily basis starting at day 50 with the M03 preparation from Example 2 (1 mg / kg / day) either by intraperitoneal injection or by oral gavage. On day 60, blood glucose levels were measured after overnight fasting. As shown in FIG. 14, with intraperitoneal administration, the control mice (N=15) had an average of 141.2 mg / dL of glucose while the mice (N=10) treated with the preparation from Example 2 had an average level of 116.8 g / dL. After administration by oral gavage, a similar effect was seen in the treated mice compared to the controls.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

The present invention relates to the field of therapeutic methods to screen for compounds on the basis of their ability to influence Wnt activity. The screening process is applied to both a physical library of a series of compounds and a virtual library of compounds that affect Wnt activity. In one aspect, the virtual screening process could be carried out where a permutational library of small peptides is substituted for the small organic molecules. The inventive methods may be used to empirically test for effects on Wnt activity and may also be applied to any pair of proteins involved in protein-protein interactions.

Description

CROSS-REFERENCE TO RELATED U.S. APPLICATIONS[0001]This application is related to U.S. patent application Ser. No. 10 / 849,643 entitled “Compositions and Methods for the Stimulation or Enhancement of Bone Formation and the Self-Renewal of Cells”, by Dan Wu, et al. filed on May 19, 2004, and its entire contents is hereby incorporated by reference, in its entirety.[0002]This application is a Continuation-in-Part of U.S. patent application Ser. No. 12 / 228,757, filed Aug. 15, 2008, which is a Continuation-in-Part of U.S. patent application Ser. No. 12 / 221,863 filed Aug. 7, 2008, which is a Continuation-in-Part of U.S. patent application Ser. No. 11 / 598,916 filed Nov. 14, 2006, which is a Continuation-in-Part of U.S. patent application Ser. No. 11 / 097,518 filed Apr. 1, 2005, which is a Continuation-in-Part of U.S. patent application Ser. No. 11 / 084,668 filed Mar. 18, 2005, which is Continuation-in-Part of U.S. patent application Ser. No. 10 / 849,067, filed May 19, 2004, the contents of all ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/02C07C309/53C07C235/56C07D251/70C07C229/66A61K31/538A61K31/196A61K31/185A61K31/277A61K31/53A61K31/245A61K31/366A61K31/12A61K31/165A61K31/167A61K31/505A61K31/122A61K31/235A61K31/05A61K31/365A61K31/343A61P31/12A61P25/00A61P19/00A61P35/00A61P3/08A61P3/06G01N33/00C12Q1/02C12Q1/68G01N33/53G01N33/542C40B30/04C40B30/02C12N5/10C12Q1/66C07D265/38G16C20/64
CPCG01N33/6845G01N2800/36A61K31/538C07D265/38G16C20/60C07D265/34A61K31/536G16B35/00C07D265/28A61P19/00A61P25/00A61P31/12A61P35/00A61P3/06A61P3/08G16C20/64
Inventor LIU, DAKAILI, XIAOFENGJIN, RICHARDLIANG, YUAXINCHENG, WEIBHATTACHARYYA, RIDDHIZHANG, GUANGRONG
Owner ENZO BIOCHEM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com